141 related articles for article (PubMed ID: 12565872)
1. Cloning and characterization of a functional promoter of the human SOCS-3 gene.
He B; You L; Uematsu K; Matsangou M; Xu Z; He M; McCormick F; Jablons DM
Biochem Biophys Res Commun; 2003 Feb; 301(2):386-91. PubMed ID: 12565872
[TBL] [Abstract][Full Text] [Related]
2. Activity of the suppressor of cytokine signaling-3 promoter in human non-small-cell lung cancer.
He B; You L; Xu Z; Mazieres J; Lee AY; Jablons DM
Clin Lung Cancer; 2004 May; 5(6):366-70. PubMed ID: 15217536
[TBL] [Abstract][Full Text] [Related]
3. Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids mRNA analysis and promoter characterization.
Paul C; Seiliez I; Thissen JP; Le Cam A
Eur J Biochem; 2000 Oct; 267(19):5849-57. PubMed ID: 10998044
[TBL] [Abstract][Full Text] [Related]
4. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.
Nicholson SE; Willson TA; Farley A; Starr R; Zhang JG; Baca M; Alexander WS; Metcalf D; Hilton DJ; Nicola NA
EMBO J; 1999 Jan; 18(2):375-85. PubMed ID: 9889194
[TBL] [Abstract][Full Text] [Related]
5. Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter.
Auernhammer CJ; Bousquet C; Melmed S
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6964-9. PubMed ID: 10359822
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
7. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
9. cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action.
Bousquet C; Chesnokova V; Kariagina A; Ferrand A; Melmed S
Mol Endocrinol; 2001 Nov; 15(11):1880-90. PubMed ID: 11682619
[TBL] [Abstract][Full Text] [Related]
10. The suppressors of cytokine signalling (SOCS).
Kile BT; Alexander WS
Cell Mol Life Sci; 2001 Oct; 58(11):1627-35. PubMed ID: 11706989
[TBL] [Abstract][Full Text] [Related]
11. Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway.
Cooney RN
Shock; 2002 Feb; 17(2):83-90. PubMed ID: 11837794
[TBL] [Abstract][Full Text] [Related]
12. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
13. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.
Niwa Y; Kanda H; Shikauchi Y; Saiura A; Matsubara K; Kitagawa T; Yamamoto J; Kubo T; Yoshikawa H
Oncogene; 2005 Sep; 24(42):6406-17. PubMed ID: 16007195
[TBL] [Abstract][Full Text] [Related]
14. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.
Bousquet C; Zatelli MC; Melmed S
J Clin Invest; 2000 Dec; 106(11):1417-25. PubMed ID: 11104795
[TBL] [Abstract][Full Text] [Related]
15. A family of cytokine-inducible inhibitors of signalling.
Starr R; Willson TA; Viney EM; Murray LJ; Rayner JR; Jenkins BJ; Gonda TJ; Alexander WS; Metcalf D; Nicola NA; Hilton DJ
Nature; 1997 Jun; 387(6636):917-21. PubMed ID: 9202125
[TBL] [Abstract][Full Text] [Related]
16. Independent roles of SOCS-3 and SHP-2 in the regulation of neuronal gene expression by leukemia inhibitory factor.
Bartoe JL; Nathanson NM
Brain Res Mol Brain Res; 2002 Nov; 107(2):108-19. PubMed ID: 12425940
[TBL] [Abstract][Full Text] [Related]
17. Novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) stimulates corticotroph function via a signal transducer and activator of transcription-dependent mechanism negatively regulated by suppressor of cytokine signaling-3.
Auernhammer CJ; Isele NB; Kopp FB; Spoettl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
Endocrinology; 2003 Apr; 144(4):1202-10. PubMed ID: 12639901
[TBL] [Abstract][Full Text] [Related]
18. JAK/STAT3 pathway is involved in survival of neurons in response to insulin-like growth factor and negatively regulated by suppressor of cytokine signaling-3.
Yadav A; Kalita A; Dhillon S; Banerjee K
J Biol Chem; 2005 Sep; 280(36):31830-40. PubMed ID: 15998644
[TBL] [Abstract][Full Text] [Related]
19. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F
Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359
[TBL] [Abstract][Full Text] [Related]
20. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer.
He B; You L; Uematsu K; Zang K; Xu Z; Lee AY; Costello JF; McCormick F; Jablons DM
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14133-8. PubMed ID: 14617776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]